J & J vaccine booster faces 'high stakes' vote

An FDA panel prepares to vote on J & J's booster, just as a new study finds J & J recipients might be better off getting a booster from a different company.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting